Health is a molecular thing: individual codes inside our body’s cells are increasingly helping doctors to precisely analyze patients. Personalized medicine makes use of knowledge about the microcosm inside us: genome-based studies and biomarkers are expanding the range of diagnostic tools available to doctors, enabling them to give cancer patients the most targeted treatment possible.
The scientists Dr. David Henderson, Dr. Oliver Politz, Dr. Monika Lessl and Dr. Joachim Reischl are searching for new biomarkers, which characterize the respective key molecules of a patient and his disease. His long term goal is to be able to compile a detailed genetic profile of a tumor through DNA analysis before a cancer patient begins treatment. In other words, cell biologists identify the altered gene sequences and give oncologists valuable starting points for highly targeted treatment.
More information on the multifaceted multimedia-experience of the title story “Personalized medicine against cancer” can be found
here.